发明公开
EP1039912A1 ANGIOSTATIC AGENTS AND COMPOSITIONS FOR CONTROLLING OCULAR HYPERTENSION 有权
血管生成抑制化合物和监测组合物中,升高的眼内压力操纵

  • 专利标题: ANGIOSTATIC AGENTS AND COMPOSITIONS FOR CONTROLLING OCULAR HYPERTENSION
  • 专利标题(中): 血管生成抑制化合物和监测组合物中,升高的眼内压力操纵
  • 申请号: EP98961956.4
    申请日: 1998-12-07
  • 公开(公告)号: EP1039912A1
    公开(公告)日: 2000-10-04
  • 发明人: CLARK, Abbot, F.
  • 申请人: ALCON LABORATORIES, INC.
  • 申请人地址: 6201 South Freeway Fort WorthTexas 76134-2099 US
  • 专利权人: ALCON LABORATORIES, INC.
  • 当前专利权人: ALCON LABORATORIES, INC.
  • 当前专利权人地址: 6201 South Freeway Fort WorthTexas 76134-2099 US
  • 代理机构: Best, Michael, Dr.
  • 优先权: US994114 19971219
  • 国际公布: WO9932127 19990701
  • 主分类号: A61K31/57
  • IPC分类号: A61K31/57 A61K31/575 A61K31/56
ANGIOSTATIC AGENTS AND COMPOSITIONS FOR CONTROLLING OCULAR HYPERTENSION
摘要:
Compositions of angiostatic agents for treating GLC1A glaucoma and methods for their use are disclosed.
信息查询
0/0